- Home
- AUTL vs SENS Comparison
AUTL vs SENS Comparison
Compare AUTL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- SENS
- Stock Information
- Founded
- AUTL 2014
- SENS 1996
- Country
- AUTL United Kingdom
- SENS United States
- Employees
- AUTL N/A
- SENS N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- SENS Industrial Machinery/Components
- Sector
- AUTL Health Care
- SENS Industrials
- Exchange
- AUTL Nasdaq
- SENS Nasdaq
- Market Cap
- AUTL 360.6M
- SENS 392.5M
- IPO Year
- AUTL 2018
- SENS N/A
- Fundamental
- Price
- AUTL $1.32
- SENS $0.63
- Analyst Decision
- AUTL Strong Buy
- SENS Strong Buy
- Analyst Count
- AUTL 5
- SENS 2
- Target Price
- AUTL $9.32
- SENS $2.00
- AVG Volume (30 Days)
- AUTL 2.4M
- SENS 3.1M
- Earning Date
- AUTL 05-08-2025
- SENS 05-08-2025
- Dividend Yield
- AUTL N/A
- SENS N/A
- EPS Growth
- AUTL N/A
- SENS N/A
- EPS
- AUTL N/A
- SENS N/A
- Revenue
- AUTL $9,011,000.00
- SENS $23,682,000.00
- Revenue This Year
- AUTL $277.74
- SENS $60.14
- Revenue Next Year
- AUTL $221.89
- SENS $36.55
- P/E Ratio
- AUTL N/A
- SENS N/A
- Revenue Growth
- AUTL N/A
- SENS 1.64
- 52 Week Low
- AUTL $1.11
- SENS $0.25
- 52 Week High
- AUTL $5.00
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- AUTL 45.63
- SENS 43.79
- Support Level
- AUTL $1.15
- SENS $0.65
- Resistance Level
- AUTL $1.44
- SENS $0.75
- Average True Range (ATR)
- AUTL 0.14
- SENS 0.05
- MACD
- AUTL 0.01
- SENS -0.00
- Stochastic Oscillator
- AUTL 29.82
- SENS 4.91
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.